Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology

Joint Authors

Hu, Yi-Yang
Gao, Shanshan
Sun, Ji-jia
Wang, Xin
Feng, Qin
Gou, Xiao-jun

Source

BioMed Research International

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-12, 12 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-11-04

Country of Publication

Egypt

No. of Pages

12

Main Subjects

Medicine

Abstract EN

Objective.

To use network pharmacology and molecular docking technology in predicting the main active ingredients and targets of Qushi Huayu Decoction (QHD) treatment in Nonalcoholic Fatty Liver Disease (NAFLD) and explore the potential mechanisms of its multi-component-multi-target-multi-pathway.

Materials and Methods.

The main chemical components of QHD were searched using traditional Chinese medicine system pharmacology technology platform (TCMSP) and PubChem database.

The main chemical components of the prescription were ADMET screened by the ACD/Labs software.

The main active ingredient was screened by 60% oral bioavailability, and 60% of “bad” ingredients were removed from the drug-like group.

Swiss Target Prediction, the SEA, and HitPick systems were sequentially used to search for the target of each active ingredient, and a network map of the QHD’s target of the active ingredient was constructed.

Genome annotation database platforms (GeneCards, OMIM, and DisGeNET) were used to predict action targets related to fatty liver disease.

“Drug-Disease-Target” network diagram could be visualized with the help of Cytoscape (3.7.1) software.

UniProt and STRING database platforms were used to build a protein interaction network.

The KEGG signal pathway and DAVID platform were analyzed for biological process enrichment.

Results.

A total of 128 active ingredients and 275 corresponding targets in QHD were discovered through screening.

55 key target targets and 27 important signaling pathways were screened, such as the cancer pathway, P13K-AKT signaling pathway, PPAR signaling pathway, and other related signaling pathways.

Conclusions.

The present study revealed the material basis of QHD and discussed the pharmacological mechanism of QHD in fatty liver, thus providing a scientific basis for the clinical application and experimental research of QHD in the future.

American Psychological Association (APA)

Gao, Shanshan& Sun, Ji-jia& Wang, Xin& Hu, Yi-Yang& Feng, Qin& Gou, Xiao-jun. 2020. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. BioMed Research International،Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1131858

Modern Language Association (MLA)

Gao, Shanshan…[et al.]. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. BioMed Research International No. 2020 (2020), pp.1-12.
https://search.emarefa.net/detail/BIM-1131858

American Medical Association (AMA)

Gao, Shanshan& Sun, Ji-jia& Wang, Xin& Hu, Yi-Yang& Feng, Qin& Gou, Xiao-jun. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. BioMed Research International. 2020. Vol. 2020, no. 2020, pp.1-12.
https://search.emarefa.net/detail/BIM-1131858

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1131858